Chronic Kidney Disease Prevalence in Patients with Colorectal Cancer Undergoing Surgery
暂无分享,去创建一个
[1] K. Christensen,et al. Cancer risk in persons with new-onset anaemia: a population-based cohort study in Denmark , 2022, BMC Cancer.
[2] M. Altıntaş,et al. Does preoperative anaemia have an effect on the perioperative period in colorectal cancer surgery? , 2022, Nigerian journal of clinical practice.
[3] Yueh-Ming Lin,et al. High Red Cell Distribution Width Is Associated with Worse Prognosis in Early Colorectal Cancer after Curative Resection: A Propensity-Matched Analysis , 2022, Cancers.
[4] B. Pereira,et al. The influence of acute kidney disease on the clinical outcomes of patients who received cisplatin, carboplatin, and oxaliplatin , 2022, Health science reports.
[5] J. Małyszko,et al. Acute kidney injury prevalence in patients with colorectal cancer undergoing surgery with curative intent , 2021, Contemporary oncology.
[6] Shruti Gupta,et al. Conventional Chemotherapy Nephrotoxicity. , 2021, Advances in chronic kidney disease.
[7] Wen-Chung Yu,et al. Pre-existing chronic kidney disease and hypertension increased the risk of cardiotoxicity among colorectal cancer patients treated with anticancer drugs , 2021, Journal of the Chinese Medical Association : JCMA.
[8] J. Rysz,et al. Nephrotoxicity as a Complication of Chemotherapy and Immunotherapy in the Treatment of Colorectal Cancer, Melanoma and Non-Small Cell Lung Cancer , 2021, International journal of molecular sciences.
[9] J. Bang,et al. Comparison of the Effects of Laparoscopic and Open Surgery on Postoperative Acute Kidney Injury in Patients with Colorectal Cancer: Propensity Score Analysis , 2021, Journal of clinical medicine.
[10] Shung-Haur Yang,et al. Prognostic value of postoperative serum carcinoembryonic antigen levels in colorectal cancer patients with chronic kidney disease. , 2020, American journal of surgery.
[11] G. Capasso,et al. The link between kidney disease and cancer: complications and treatment , 2020, The Lancet.
[12] R. Labianca,et al. Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] A. Batra,et al. Eligibility of Real-World Patients With Stage II and III Colon Cancer for Adjuvant Chemotherapy Trials. , 2020, Clinical colorectal cancer.
[14] H. Lee,et al. The Combined Impact of Chronic Kidney Disease and Diabetes on the Risk of Colorectal Cancer Depends on Sex: A Nationwide Population-Based Study , 2020, Yonsei medical journal.
[15] J. Małyszko,et al. Hypertension and chronic kidney disease is highly prevalent in elderly patients with colorectal cancer undergoing primary surgery. , 2019, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[16] Sum-Fu Chiang,et al. The impact of kidney function on colorectal cancer patients with localized and regional diseases: An observational study from Taiwan , 2019, Indian journal of cancer.
[17] H. Sørensen,et al. Acute kidney injury and 1-year mortality after colorectal cancer surgery: a population-based cohort study , 2019, BMJ Open.
[18] K. Oh,et al. Oxaliplatin-induced acute tubulointerstitial nephritis: Two case reports . , 2017, Clinical nephrology.
[19] A. Ido,et al. Risk of Colorectal Cancer in Chronic Kidney Disease: A Systematic Review and Meta-Analysis , 2017, Journal of clinical gastroenterology.
[20] Linda T. Li,et al. Ileostomy creation in colorectal cancer surgery: risk of acute kidney injury and chronic kidney disease. , 2017, The Journal of surgical research.
[21] G. Deray,et al. Renal insufficiency and cancer treatments , 2016, ESMO Open.
[22] C. Grines,et al. Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue , 2016, Circulation.
[23] Seung-Yong Jeong,et al. Colorectal Cancer Incidence in Korea Is Not the Highest in the World , 2016, Cancer research and treatment : official journal of Korean Cancer Association.
[24] O. Faiz,et al. Impact of chronic kidney disease on postoperative outcome following colorectal cancer surgery , 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[25] C. Teng,et al. Early Colonoscopy Confers Survival Benefits on Colon Cancer Patients with Pre-Existing Iron Deficiency Anemia: A Nationwide Population-Based Study , 2014, PloS one.
[26] M. Lipman,et al. Severe acute tubular necrosis observed subsequent to oxaliplatin administration , 2013, Clinical kidney journal.
[27] I. Sporea,et al. Aspects of renal function in patients with colorectal cancer in a gastroenterology clinic of a county hospital in Western Romania. , 2013, Romanian journal of internal medicine = Revue roumaine de medecine interne.
[28] Mei-Yi Wu,et al. Risk of Colorectal Cancer in Chronic Kidney Disease: A Matched Cohort Study Based on Administrative Data , 2013, Annals of Surgical Oncology.
[29] Jong-Youl Jin,et al. The prevalence and clinical characteristics of cancer among anemia patients treated at an outpatient clinic , 2013, Blood research.
[30] E. Sunami,et al. Impact of Chronic Kidney Disease on Outcomes of Surgical Resection for Primary Colorectal Cancer: A Retrospective Cohort Review , 2012, Diseases of the colon and rectum.
[31] Josef Coresh,et al. Chronic kidney disease , 2012, The Lancet.
[32] A. Jemal,et al. Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.
[33] W. Hamilton,et al. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients , 2009, British Journal of Cancer.
[34] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[35] B. Souweine,et al. Oxaliplatin-induced acute renal failure presenting clinically as thrombotic microangiopathy: think of acute tubular necrosis , 2009, NDT plus.
[36] A. Więcek,et al. Early Detection of Chronic Kidney Disease: Results of the PolNef Study , 2008, American Journal of Nephrology.
[37] E. Król,et al. Epidemiology of Chronic Kidney Disease in Central and Eastern Europe , 2008, Blood Purification.
[38] T. Peters,et al. The importance of anaemia in diagnosing colorectal cancer: a case–control study using electronic primary care records , 2008, British Journal of Cancer.
[39] Sheena Derry,et al. Prevalence of anaemia in older persons: systematic review , 2008, BMC geriatrics.
[40] S. Oudard,et al. Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management , 2007, Cancer.
[41] Lisa Wang,et al. Potential drug interactions and duplicate prescriptions among cancer patients. , 2007, Journal of the National Cancer Institute.
[42] I. Dahabreh,et al. Hemolytic uremic syndrome following the infusion of oxaliplatin: case report , 2006, BMC clinical pharmacology.
[43] E. Beutler,et al. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? , 2006, Blood.
[44] F. Lordick,et al. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] J. Sørensen,et al. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine , 2006, Cancer Chemotherapy and Pharmacology.
[46] T. Peters,et al. Clinical features of colorectal cancer before diagnosis: a population-based case–control study , 2005, British Journal of Cancer.
[47] L. Noël,et al. Renal toxicity of oxaliplatin. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[48] Dirk Schrijvers,et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. , 2004, European journal of cancer.
[49] R. Stewart,et al. Iron deficiency anaemia in general practice: clinical outcomes over three years and factors influencing diagnostic investigations , 2004, Postgraduate Medical Journal.
[50] Deeb N Salem,et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.
[51] R. Riccardi,et al. Cellular and molecular aspects of drugs of the future: oxaliplatin , 2002, Cellular and Molecular Life Sciences CMLS.
[52] D. Kendrick,et al. Investigation and management of iron deficiency anaemia in general practice: a cluster randomised controlled trial of a simple management prompt , 2002, Postgraduate medical journal.
[53] E. Picano,et al. Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil. , 2001, The American journal of medicine.
[54] J. Caro,et al. Anemia as an independent prognostic factor for survival in patients with cancer , 2001 .
[55] E. Cohen,et al. RADIATION NEPHROPATHY , 1976, The Lancet.
[56] L. Tanoue. Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths , 2012 .
[57] E. McLean,et al. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. , 2008 .
[58] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.